Coulter JA - Search Results

1

Enhanced nanoparticle delivery exploiting tumour-responsive formulations.

Bennie LA, McCarthy HO, Coulter JA. Bennie LA, et al. Among authors: coulter ja. Cancer Nanotechnol. 2018;9(1):10. doi: 10.1186/s12645-018-0044-6. Epub 2018 Nov 21. Cancer Nanotechnol. 2018. PMID: 30595759 Free PMC article. Review.

2

Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.

McCarthy HO, Coulter JA, Worthington J, Robson T, Hirst DG. McCarthy HO, et al. Among authors: coulter ja. J Gene Med. 2007 Jun;9(6):511-20. doi: 10.1002/jgm.1045. J Gene Med. 2007. PMID: 17471586

3

The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.

Coulter JA, McCarthy HO, Worthington J, Robson T, Scott S, Hirst DG. Coulter JA, et al. Gene Ther. 2008 Apr;15(7):495-503. doi: 10.1038/gt.2008.7. Epub 2008 Feb 7. Gene Ther. 2008. PMID: 18256696

4

Nitric oxide--a novel therapeutic for cancer.

Coulter JA, McCarthy HO, Xiang J, Roedl W, Wagner E, Robson T, Hirst DG. Coulter JA, et al. Nitric Oxide. 2008 Sep;19(2):192-8. doi: 10.1016/j.niox.2008.04.023. Epub 2008 Apr 29. Nitric Oxide. 2008. PMID: 18485922 Review.

5

Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions.

McCarthy HO, Coulter JA, Robson T, Hirst DG. McCarthy HO, et al. Among authors: coulter ja. J Pharm Pharmacol. 2008 Aug;60(8):999-1017. doi: 10.1211/jpp.60.8.0007. J Pharm Pharmacol. 2008. PMID: 18644193 Review.

6

Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells.

Adams C, McCarthy HO, Coulter JA, Worthington J, Murphy C, Robson T, Hirst DG. Adams C, et al. Among authors: coulter ja. J Gene Med. 2009 Feb;11(2):160-8. doi: 10.1002/jgm.1280. J Gene Med. 2009. PMID: 19062185

7

Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy.

Butterworth KT, Coulter JA, Jain S, Forker J, McMahon SJ, Schettino G, Prise KM, Currell FJ, Hirst DG. Butterworth KT, et al. Among authors: coulter ja. Nanotechnology. 2010 Jul 23;21(29):295101. doi: 10.1088/0957-4484/21/29/295101. Epub 2010 Jul 5. Nanotechnology. 2010. PMID: 20601762 Free PMC article.

8

Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancer.

Coulter JA, Page NL, Worthington J, Robson T, Hirst DG, McCarthy HO. Coulter JA, et al. J Gene Med. 2010 Sep;12(9):755-65. doi: 10.1002/jgm.1495. J Gene Med. 2010. PMID: 20821746

9

The contribution of N₂O₃ to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylation.

Ali AA, Coulter JA, Ogle CH, Migaud MM, Hirst DG, Robson T, McCarthy HO. Ali AA, et al. Among authors: coulter ja. Biosci Rep. 2013 Mar 28;33(2):e00031. doi: 10.1042/BSR20120120. Biosci Rep. 2013. PMID: 23402389 Free PMC article.

10

CD44 increases the efficiency of distant metastasis of breast cancer.

McFarlane S, Coulter JA, Tibbits P, O'Grady A, McFarlane C, Montgomery N, Hill A, McCarthy HO, Young LS, Kay EW, Isacke CM, Waugh DJ. McFarlane S, et al. Among authors: coulter ja. Oncotarget. 2015 May 10;6(13):11465-76. doi: 10.18632/oncotarget.3410. Oncotarget. 2015. PMID: 25888636 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page